Teladoc Health (TDOC) Research & Development (2016 - 2025)
Teladoc Health (TDOC) has disclosed Research & Development for 12 consecutive years, with $71.6 million as the latest value for Q4 2025.
- Quarterly Research & Development fell 6.7% to $71.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $277.9 million through Dec 2025, down 9.55% year-over-year, with the annual reading at $277.9 million for FY2025, 9.55% down from the prior year.
- Research & Development hit $71.6 million in Q4 2025 for Teladoc Health, up from $67.6 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $89.9 million in Q4 2023 to a low of $67.6 million in Q3 2025.
- Historically, Research & Development has averaged $79.0 million across 5 years, with a median of $79.5 million in 2021.
- Biggest YoY gain for Research & Development was 305.09% in 2021; the steepest drop was 21.39% in 2021.
- Year by year, Research & Development stood at $72.9 million in 2021, then increased by 13.81% to $82.9 million in 2022, then rose by 8.45% to $89.9 million in 2023, then dropped by 14.66% to $76.8 million in 2024, then fell by 6.7% to $71.6 million in 2025.
- Business Quant data shows Research & Development for TDOC at $71.6 million in Q4 2025, $67.6 million in Q3 2025, and $68.8 million in Q2 2025.